Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemia [3]
Research output: Contribution to journal › Letter › peer-review
17Scopus
citations
Fingerprint
Dive into the research topics of 'Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemia [3]'. Together they form a unique fingerprint.
Medicine and Dentistry
Nursing and Health Professions
Pharmacology, Toxicology and Pharmaceutical Science